134 related articles for article (PubMed ID: 34836744)
1. Neuroprotective effect of pseudoginsenoside-F11 on permanent cerebral ischemia in rats by regulating calpain activity and NR2A submit-mediated AKT-CREB signaling pathways.
Liu Y; Fu X; Liu Y; Zhang T; Cui P; Wang S; Liu L; Hou Z; Wang H; Zhao Y; Zhang Z; Zhang H; Wu C; Yang J
Phytomedicine; 2022 Feb; 96():153847. PubMed ID: 34836744
[TBL] [Abstract][Full Text] [Related]
2. Pseudoginsenoside F11 ameliorates the dysfunction of the autophagy-lysosomal pathway by activating calcineurin-mediated TFEB nuclear translocation in neuron during permanent cerebral ischemia.
Fu X; Liu Y; Zhang H; Yu X; Wang X; Wu C; Yang J
Exp Neurol; 2021 Apr; 338():113598. PubMed ID: 33422553
[TBL] [Abstract][Full Text] [Related]
3. Pseudoginsenoside-F11 Protects against Transient Cerebral Ischemia Injury in Rats Involving Repressing Calcium Overload.
Zhang T; Wu C; Yang X; Liu Y; Yang H; Yuan L; Liu Y; Sun S; Yang J
Neuroscience; 2019 Jul; 411():86-104. PubMed ID: 31129202
[TBL] [Abstract][Full Text] [Related]
4. Pseudoginsenoside-F11 promotes functional recovery after transient cerebral ischemia by regulating the microglia/macrophage polarization in rats.
Hou Y; Yang D; Wang X; Wang H; Zhang H; Wang P; Liu Y; Gao X; Yang J; Wu C
Int Immunopharmacol; 2021 Oct; 99():107896. PubMed ID: 34246061
[TBL] [Abstract][Full Text] [Related]
5. Pseudoginsenoside-F11 attenuates cerebral ischemic injury by alleviating autophagic/lysosomal defects.
Liu YY; Zhang TY; Xue X; Liu DM; Zhang HT; Yuan LL; Liu YL; Yang HL; Sun SB; Zhang C; Xu HS; Wu CF; Yang JY
CNS Neurosci Ther; 2017 Jul; 23(7):567-579. PubMed ID: 28485547
[TBL] [Abstract][Full Text] [Related]
6. Pseudoginsenoside-F11 improves long-term neurological function and promotes neurogenesis after transient cerebral ischemia in mice.
Yuan L; Sun S; Pan X; Zheng L; Li Y; Yang J; Wu C
Neurochem Int; 2020 Feb; 133():104586. PubMed ID: 31756514
[TBL] [Abstract][Full Text] [Related]
7. Pseudoginsenoside-F11 Accelerates Microglial Phagocytosis of Myelin Debris and Attenuates Cerebral Ischemic Injury Through Complement Receptor 3.
Liu Y; Wu C; Hou Z; Fu X; Yuan L; Sun S; Zhang H; Yang D; Yao X; Yang J
Neuroscience; 2020 Feb; 426():33-49. PubMed ID: 31790669
[TBL] [Abstract][Full Text] [Related]
8. Pseudoginsenoside-F11 ameliorates ischemic neuron injury by regulating the polarization of neutrophils and macrophages in vitro.
Hou Y; Yang D; Zhang Q; Wang X; Yang J; Wu C
Int Immunopharmacol; 2020 Aug; 85():106564. PubMed ID: 32447220
[TBL] [Abstract][Full Text] [Related]
9. Pseudoginsenoside-F11 (PF11) exerts anti-neuroinflammatory effects on LPS-activated microglial cells by inhibiting TLR4-mediated TAK1/IKK/NF-κB, MAPKs and Akt signaling pathways.
Wang X; Wang C; Wang J; Zhao S; Zhang K; Wang J; Zhang W; Wu C; Yang J
Neuropharmacology; 2014 Apr; 79():642-56. PubMed ID: 24467851
[TBL] [Abstract][Full Text] [Related]
10. Activation of NR2A receptors induces ischemic tolerance through CREB signaling.
Terasaki Y; Sasaki T; Yagita Y; Okazaki S; Sugiyama Y; Oyama N; Omura-Matsuoka E; Sakoda S; Kitagawa K
J Cereb Blood Flow Metab; 2010 Aug; 30(8):1441-9. PubMed ID: 20145658
[TBL] [Abstract][Full Text] [Related]
11. Pseudoginsenoside-F11 attenuates cognitive dysfunction and tau phosphorylation in sporadic Alzheimer's disease rat model.
Zhu L; Hou XJ; Che XH; Zhou TS; Liu XQ; Wu CF; Yang JY
Acta Pharmacol Sin; 2021 Sep; 42(9):1401-1408. PubMed ID: 33277592
[TBL] [Abstract][Full Text] [Related]
12. Nobiletin protects against cerebral ischemia via activating the p-Akt, p-CREB, BDNF and Bcl-2 pathway and ameliorating BBB permeability in rat.
Zhang L; Zhao H; Zhang X; Chen L; Zhao X; Bai X; Zhang J
Brain Res Bull; 2013 Jul; 96():45-53. PubMed ID: 23644141
[TBL] [Abstract][Full Text] [Related]
13. Pseudoginsenoside-F11 ameliorates thromboembolic stroke injury in rats by reducing thromboinflammation.
Gao Y; Liu Y; Yang X; Zhang T; Hou Y; Wang P; Liu Y; Yuan L; Zhang H; Wu C; Yang J
Neurochem Int; 2021 Oct; 149():105108. PubMed ID: 34175350
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3β and CREB through PI3-K/Akt pathways.
Simão F; Matté A; Pagnussat AS; Netto CA; Salbego CG
Eur J Neurosci; 2012 Oct; 36(7):2899-905. PubMed ID: 22817531
[TBL] [Abstract][Full Text] [Related]
15. BDNF/PI3K/Akt and Nogo-A/RhoA/ROCK signaling pathways contribute to neurorestorative effect of Houshiheisan against cerebral ischemia injury in rats.
Chang J; Yao X; Zou H; Wang L; Lu Y; Zhang Q; Zhao H
J Ethnopharmacol; 2016 Dec; 194():1032-1042. PubMed ID: 27833029
[TBL] [Abstract][Full Text] [Related]
16. Prosurvival NMDA 2A receptor signaling mediates postconditioning neuroprotection in the hippocampus.
Zhang X; Zhang Q; Tu J; Zhu Y; Yang F; Liu B; Brann D; Wang R
Hippocampus; 2015 Mar; 25(3):286-96. PubMed ID: 25271147
[TBL] [Abstract][Full Text] [Related]
17. The combination of Astragalus membranaceus and ligustrazine mitigates cerebral ischemia-reperfusion injury via regulating NR2B-ERK/CREB signaling.
Tang X; Xie S; Wang H; Li Y; Lai Z; Sun S; Pan R; Huang Y; Cai J
Brain Behav; 2023 Feb; 13(2):e2867. PubMed ID: 36585899
[TBL] [Abstract][Full Text] [Related]
18. 2-(4-Methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside confers neuroprotection in cell and animal models of ischemic stroke through calpain1/PKA/CREB-mediated induction of neuronal glucose transporter 3.
Yu S; Cheng Q; Li L; Liu M; Yang Y; Ding F
Toxicol Appl Pharmacol; 2014 Jun; 277(3):259-69. PubMed ID: 24726522
[TBL] [Abstract][Full Text] [Related]
19. Diterpene ginkgolides protect against cerebral ischemia/reperfusion damage in rats by activating Nrf2 and CREB through PI3K/Akt signaling.
Zhang W; Song JK; Yan R; Li L; Xiao ZY; Zhou WX; Wang ZZ; Xiao W; Du GH
Acta Pharmacol Sin; 2018 Aug; 39(8):1259-1272. PubMed ID: 29542683
[TBL] [Abstract][Full Text] [Related]
20. Differential roles of NMDA receptor subtypes in ischemic neuronal cell death and ischemic tolerance.
Chen M; Lu TJ; Chen XJ; Zhou Y; Chen Q; Feng XY; Xu L; Duan WH; Xiong ZQ
Stroke; 2008 Nov; 39(11):3042-8. PubMed ID: 18688011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
